Sourav De | Medicinal Chemistry | Best Researcher Award

Dr. Sourav De | Medicinal Chemistry | Best Researcher Award

Eminent College of Pharmaceutical Technology, India

👨‍🎓Profiles

🎓 Education and Academic Background

Dr. Sourav De is a distinguished researcher and educator currently affiliated with Eminent College of Pharmaceutical Technology, India. He earned his Doctor of Philosophy (Ph.D.) in Chemistry from the School of Advanced Sciences, Vellore Institute of Technology (VIT), India (March 2017 – December 2020). Under the guidance of Dr. S. K. Ashok Kumar, Professor, his doctoral thesis focused on the design, synthesis, characterization, and anticancer evaluation of various heterocycles and Ru(II)-arene-N^N, N^O, N^S complexes. His strong academic foundation also includes an M.Pharm in Pharmaceutical Chemistry from West Bengal University of Technology (2010–2012), where he graduated with a CGPA of 8.79 (First Class), and a B.Pharm from the University of North Bengal (2006–2010), securing 74% (First Class).

🔬 Research Interests

Dr. Sourav De’s research interests span a diverse range of medicinal chemistry and organometallic chemistry, with a strong emphasis on the therapeutic applications of organic and organometallic complexes. His key areas of focus include: Molecular Modeling and In-Silico Studies for drug discovery and computational chemistry. Chromogenic and Fluorogenic Sensors for biomedical and pharmaceutical applications. Cancer Research, particularly in the treatment of cervical, colon, breast, and brain tumors.

🏆 Research Projects

Dr. De has actively contributed to multiple academic research and technology development projects, showcasing his expertise in cancer theranostics, drug discovery, and molecular design. Notable projects include: DST-SERB Sponsored Project: He worked as a Project Assistant on the Development of novel 2-aryl benzothiazole/benzoxazole, quinoxaline, and phenanthroline analogues as fluorescent probes and cancer theranostics applications (EMR/2017/000816). Grant-in-Aid SEED Fund Research Project: As a Principal Investigator, he led a research project titled “In silico analysis of some ruthenium complexes as potential anti-cancer agents,” funded by Rs. 85,000 (AU/REG/NOT/2021/04/003). With over 11 years and 9 months of research experience, Dr. De has made impactful contributions to the fields of drug development and computational chemistry.

🛠️ Technical Skills

Dr. Sourav De possesses strong technical expertise across various analytical instruments, imaging techniques, and computational tools. His skill set includes: Instruments Handled: UV, FL, FTIR, CD spectroscopy, ELISA reader, Gel Doc, and HPLC. Imaging Techniques: Fluorescent Microscopy, Scanning Electron Microscopy (SEM), and Flow Cytometry. Computational and Analytical Tools: Molecular Modeling & Docking: AutoDock 4.2, AutoDock Vina, Chimera 1.11rc, Open Babel GUI. Data Analysis: Python for scientific computing and data visualization. Plotting and Molecular Visualization: Origin, ChemDraw, ChemSketch. Hands-on Experience: Cell culture, molecular biology, and bioinformatics for drug-target interactions and cancer research.

📚 Teaching Experience

Dr. De is an experienced educator specializing in pharmaceutical and medicinal chemistry. He has taught various subjects, including: Pharmaceutical Chemistry & Medicinal Chemistry, Organic and Inorganic Chemistry, Pharmaceutical Analysis & Instrumental Analysis. His teaching methodology combines practical applications and research-driven insights, ensuring students gain both theoretical knowledge and hands-on experience.

🌟 Future Research and Contributions

Dr. Sourav De is committed to advancing therapeutic drug design, molecular diagnostics, and cancer research. His future work aims to develop targeted anticancer drugs, bioactive organometallic complexes, and AI-driven molecular modeling techniques. With his expertise in pharmaceutical sciences and computational chemistry, he continues to make significant contributions to drug discovery and medicinal research.

📖Notable Publications

  • Pyridine: the scaffolds with significant clinical diversity

    • Authors: S De, AK SK, SK Shah, S Kazi, N Sarkar, S Banerjee, S Dey
    • Journal: RSC Advances
    • Year: 2022
  • Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer

    • Authors: S De, S Banerjee, SKA Kumar, P Paira
    • Journal: Mini Reviews in Medicinal Chemistry
    • Year: 2019
  • Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium (II)–arene-2-heteroarylbenzoxazole complexes

    • Authors: S De, SR Chaudhuri, A Panda, GR Jadhav, RS Kumar, P Manohar, …
    • Journal: New Journal of Chemistry
    • Year: 2019
  • Amberlite IR-120 (H) mediated “on water” synthesis of fluorescent Ruthenium (II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging

    • Authors: A Mondal, S De, S Maiti, B Sarkar, AK Sk, R Jacob, A Moorthy, P Paira
    • Journal: Journal of Photochemistry and Photobiology B: Biology
    • Year: 2018
  • Luminescent ruthenium (II)-para-cymene complexes of aryl substituted imidazo-1,10-phenanthroline as anticancer agents and the effect of remote substituents on cytotoxic activities

    • Authors: S De, RS Kumar, A Gauthaman, SKA Kumar, P Paira, A Moorthy, …
    • Journal: Inorganica Chimica Acta
    • Year: 2021

Fei Yao | Biochemistry | Best Researcher Award

Prof. Fei Yao | Biochemistry | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University, China

👨‍🎓Profiles

🎓 Early Academic Pursuits

Prof. Fei Yao’s journey in academia began with a strong foundation in biochemistry and medical sciences. With a keen interest in cancer biology, Prof. Yao pursued higher education in oncology, eventually earning a medical degree and further advancing into postdoctoral research. This rigorous academic training laid the groundwork for future contributions to cancer research.

🏥 Professional Endeavors

Currently serving as a Professor of Oncology at The First Affiliated Hospital of Guangxi Medical University, China, and The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Prof. Yao has seamlessly integrated clinical expertise with research innovations. As a medical doctor and postdoctoral fellow, Prof. Yao also mentors master’s students, shaping the next generation of researchers in oncology and biochemistry.

🔬 Contributions and Research Focus

Prof. Yao’s research primarily focuses on tumor microenvironment mechanisms and the development of clinical drugs for cancer treatment. By leading multiple prestigious research projects funded by:

  • 🏅 National Natural Science Foundation of China
  • 🏅 China Postdoctoral Science Foundation
  • 🏅 Guangxi Natural Science Foundation

Prof. Yao has significantly contributed to understanding how cancer cells interact with their surroundings, paving the way for novel therapeutic strategies.

📚 Impact and Influence

Prof. Yao has published multiple SCI-indexed research papers, adding valuable insights to the field of oncology and biochemistry. These studies have not only been widely cited but have also influenced clinical applications and drug development in cancer research.

📖 Academic Citations & Recognition

With a robust research portfolio, Prof. Yao’s work has been cited extensively in international journals, reinforcing its scientific impact. These contributions continue to shape the landscape of cancer treatment and personalized medicine.

🛠️ Technical Skills & Expertise

Prof. Yao possesses expertise in various advanced biochemical and clinical research techniques, including:
✔️ Tumor Microenvironment Analysis
✔️ Cell Culture & Molecular Biology Techniques
✔️ Targeted Drug Development for Cancer
✔️ Clinical Trials & Experimental Therapies
✔️ Biostatistical Analysis & Research Methodologies

🎓 Teaching and Mentorship

As a Master’s Supervisor, Prof. Yao plays a crucial role in mentoring graduate students, guiding them in research methodologies, experimental designs, and thesis development. Many students have benefited from this mentorship, progressing in their careers as medical researchers and clinicians.

🌎 Legacy and Future Contributions

With a deep commitment to advancing cancer research, Prof. Yao aims to:
🔹 Continue exploring innovative treatments targeting the tumor microenvironment.
🔹 Bridge the gap between traditional Chinese medicine and modern oncology.
🔹 Develop next-generation clinical drugs to improve patient outcomes.
🔹 Inspire young researchers to contribute meaningfully to biochemistry and oncology.

🏆 Conclusion

Prof. Fei Yao’s dedication to biochemistry and cancer research has established a remarkable legacy in oncology, drug development, and clinical applications. As an esteemed professor, researcher, and mentor, Prof. Yao’s contributions will continue to impact the field for years to come.

📖Notable Publications

Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients

Authors: L. Zhong, L. Gan, B. Wang, W. Shi, Y. Zhao

Journal: Cell

Year: 2025